The prevalence of PAI-1 4G/5G gene variant in Serbian population

V Đorđević, M Gvozdenov, I Pruner… - … Specijalne bolnice za …, 2013 - scindeks.ceon.rs
Introduction: Plasminogen activator inhibitor 1 (PAI-1) has a major role in inhibition of
firinolysis and normal haemostasis. The presence of the PAI-1 4G/4G genotype leads to …

Genetic disorders in Lebanon

VM Der Kaloustian - Genetic disorders among Arab populations, 2010 - Springer
Lebanon is one of the countries in the Arab World that developed services of medical
genetics relatively early (Der Kaloustian et al. 1980). In this, it followed the developed …

Učestalost PAI-1 4g/5g genske varijante u srpskoj populaciji

V Đorđević, M Gvozdenov, I Pruner… - … bolnice za bolesti …, 2013 - imagine.imgge.bg.ac.rs
Uvod: Inhibitor aktivatora plazminogena 1 (PAI-1) ima značajnu ulogu u procesu inhibicije
fibrinolize i normalne hemostaze. Prisustvo PAI-1 4G/4G genotipa uzrokuje povećanje …

[PDF][PDF] Association of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G and Apolipoprotein E polymorphisms with risk of Myocardial Infarction in Indian Tamil Population

P Pournima, SB Abirami, A Devi… - Research Journal of …, 2018 - researchgate.net
Cardiovascular disease CVD is a major threat in South India and yields high mortality rates.
In this study, we investigated the association of apolipoprotein E (APOE) and the …

Association of 4G/5G polymorphism in Plasminogen activator inhibitor-inhibitor (PAI-1) gene with thrombosis in coronary arteries

M Sakhteh, B Poopak, N Amirizadeh… - Scientific Journal of …, 2015 - bloodjournal.ir
با ترومبوز شرياني در عروق كرونر ) ( PAI-1 -1 كننده پالسمينوژن در ژن مهاركنن Page 1 23 هرود 11
هرامش 1 راهب 39 ( 04 - 93 ) يشهوژپ هلاقم يلپ طابترا مسيفروم 4G/5G لاعف هدننكراهم نژ رد …

[PDF][PDF] ARMS (ﺎﺑ

S Out - researchgate.net
ﺑﺎ ﺗﺮﻭﻣﺒﻮﺯ ﺷﺮﻳﺎﻧﻲ ﺩﺭ ﻋﺮﻭﻕ ﻛﺮﻭﻧﺮ ( ) PAI-1 -۱ ﻛﻨﻨﺪﻩ ﭘﻼﺳﻤ Page 1 ٣٢ ﻩﺭﻭﺩ ۱۱ ﻩﺭﺎﻤﺷ ۱ ﺭﺎﻬﺑ ۹۳ ) ۴۰ ۳۲ ( ﻲﺸﻫﻭﮋﭘ
ﻪﻟﺎﻘﻣ ﻲﻠﭘ ﻁﺎﺒﺗﺭﺍ ﻢﺴﻴﻓﺭﻮﻣ 4G/5G ﻝﺎﻌﻓ ﻩﺪﻨﻨﻛﺭﺎﻬﻣ ﻥﮊ ﺭﺩ ﻥﮊﻮﻨﻴﻤﺳﻼﭘ ﻩﺪﻨﻨﻛ -۱ ) PAI-1 ( ﺮﻧﻭﺮﻛ ﻕﻭﺮﻋ ﺭﺩ ﻲﻧﺎﻳﺮﺷ ﺯﻮﺒﻣﻭﺮﺗ ﺎﺑ …

Učestalost polimorfizma PAI-1 4G/5G kod žena sa spontanim pobačajem-prvi podaci za srpsku populaciju

V Đorđević, M Gvozdenov, I Pruner… - Journal of Medical …, 2014 - imagine.imgge.bg.ac.rs
Uvod: Inhibitor aktivatora plazminogena 1 (PAI-1) igra značajnu ulogu u procesu inhibicije
fibrinolize. Pokazano je da je PAI-1 4G/5G polimorfizam povezan sa povišenim nivoom PAI …

[PDF][PDF] THE PREVALENCE OF PAI-1 4G/5G GENE VARIANT IN SERBIAN POPULATION

Đ Valentina, G Maja, P Iva, T Branko, K Mirjana… - cigota-rs.radionicakrug.com
Introduction: Plasminogen activator inhibitor 1 (PAI-1) has a major role in inhibition of
fibrinolysis and normal haemostasis. The presence of the PAI-1 4G/4G genotype leads to …

[PDF][PDF] UČESTALOST PAI-1 4G/5G GENSKE VARIJANTE U SRPSKOJ POPULACIJI

Đ Valentina, G Maja, P Iva, T Branko, K Mirjana… - Medical Gazette …, 2013 - Citeseer
Metode: Studija je obuhvatala grupu od 210 zdravih ispitanika (105 žena i 105 muškaraca).
Prisustvo PAI-1 4G/5G genske varijante detektovano je PCR-RFLP metodom. Rezultati …

[引用][C] THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS–FIRST DATA FOR A SERBIAN POPULATION/UČESTALOST …

D Radojković - Journal of Medical Biochemistry - sciendo.com
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Over-expression …